| Title |
Benzodiazepines versus placebo for panic disorder in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2019
|
| DOI | 10.1002/14651858.cd010677.pub2 |
| Pubmed ID | |
| Authors |
Johanna Breilmann, Francesca Girlanda, Giuseppe Guaiana, Corrado Barbui, Andrea Cipriani, Mariasole Castellazzi, Irene Bighelli, Simon JC Davies, Toshi A Furukawa, Markus Koesters |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 11% |
| Spain | 4 | 11% |
| United Kingdom | 3 | 8% |
| Japan | 2 | 5% |
| Chile | 1 | 3% |
| Canada | 1 | 3% |
| New Zealand | 1 | 3% |
| El Salvador | 1 | 3% |
| Ireland | 1 | 3% |
| Other | 3 | 8% |
| Unknown | 16 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 28 | 76% |
| Practitioners (doctors, other healthcare professionals) | 5 | 14% |
| Scientists | 4 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 347 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 346 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 41 | 12% |
| Student > Bachelor | 40 | 12% |
| Researcher | 28 | 8% |
| Student > Doctoral Student | 25 | 7% |
| Other | 19 | 5% |
| Other | 58 | 17% |
| Unknown | 136 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 87 | 25% |
| Psychology | 32 | 9% |
| Nursing and Health Professions | 22 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 3% |
| Biochemistry, Genetics and Molecular Biology | 8 | 2% |
| Other | 32 | 9% |
| Unknown | 155 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2023.
All research outputs
#1,116,698
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#2,240
of 13,140 outputs
Outputs of similar age
#25,534
of 365,564 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 184 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,564 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 184 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.